On Thursday shares of Delta Air Lines, Inc. (NYSE:DAL) closed at $46.43. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 19.25%. Delta Air Lines, Inc. (NYSE:DAL) announced it will suspend service to Moscow during the final three months of this year, meaning that no U.S. passenger carrier will fly to the Russian capital during that period.
Cisco Systems, Inc. (NASDAQ:CSCO) in last trading activity moved up 0.19% to close at $28.67. Company weekly performance is 0.26% while its quarterly performance stands at 1.38%. Cisco Systems, Inc. (NASDAQ:CSCO) is -4.67% away from its 52 week high. Cisco Systems, Inc. (NASDAQ:CSCO) announced an agreement with Altice to deploy a next-generation converged cable access platform across its multi-country footprint, with the first rollouts being done in France.
On last trading day RMG Networks Holding Corporation (NASDAQ:RMGN) increased 4.83% to close at $1.52. Its volatility for the week is 10.80% while volatility for the month is 10.50%. RMG Networks Holding Corporation (NASDAQ:RMGN) monthly performance is 0.66%. On 16 April, RMG Networks Holding Corporation (NASDAQ:RMGN) announced the introduction of its new Labor Productivity Improvement solution for supply chain warehouses and distribution centers that is designed to improve supply chain efficiency by up to 20 percent.
On last trading day Caterpillar Inc. (NYSE:CAT) fell -0.09% to close at $84.79. Its volatility for the week is 2.07% while volatility for the month is 1.78%. CAT’s sales growth for past 5 years was 11.20% and its EPS growth for past 5 years was 32.70%. Caterpillar Inc. (NYSE:CAT) monthly performance is 6.23%. Caterpillar Inc. (NYSE:CAT) publicized its earnings report for the first quarter of its fiscal year 2015 (1QFY15). It recorded quarterly net earnings of $12.70 billion, beating the market expectation by $320 million. However, despite beating expectations the company recorded a Year-over-Year (YoY) decline of more than 4%.
On last trading day Seattle Genetics, Inc. (NASDAQ:SGEN) increased 1.56% to close at $37.50. Its volatility for the week is 2.96% while volatility for the month is 3.52%. SGEN’s sales growth for past 5 years was 40.70% and its EPS growth for past 5 years was 7.20%. Seattle Genetics, Inc. (NASDAQ:SGEN) monthly performance is -0.50%. On 21 April, Seattle Genetics, Inc. (NASDAQ:SGEN) announced that the FDA has accepted its supplemental Biologics License Application (BLA) for Adcetris for priority review for as consolidation therapy immediately following an autologous stem cell transplant (ASCT) in patients suffering from Hodgkin’s lymphoma, who are at high risk of relapse or progression.